今开:0.0 | 昨收:11.83 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:6.21202587E8 |
chuminhua2023-01-31 12:19
1月30日,FDA 宣布批准 Stemline Therapeutics $Stemline医疗(STML)$ 的 口服选择性雌激素受体降解剂(SERD)Orserdu(elacestrant)用于患有 ER+/HER2-、ESR1 突变的晚期或转移性乳腺癌且在至少一种内分泌治疗后疾病进展的绝经后女性或成年男性。 该机构去年给与该申请优先审评。网页链接查看全文
牛唐2020-01-16 21:55
研发类药企商业化任重道远,成功概率小,多半是好药在手,难以销售$Portola制药(PTLA)$ $Stemline医疗(STML)$ 就是这个道理。$欢聚时代(YY)$查看全文
$Stemline医疗(STML)$ 内部交易: 2019-12-02,Director,Forman Alan S ,买入,1000普通股, $10.29
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-19-070016 Size: 4 KB 网页链接
$Stemline医疗(STML)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001104659-19-062655 Act: 34 Size: 8 MB 网页链接
$Stemline医疗(STML)$ 8-K - Current report Filed: 2019-11-07 AccNo: 0001104659-19-061232 Size: 195 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Stemline医疗(STML)$ 内部交易: 2019-08-14,CEO,Bergstein Ivan ,卖出,35010普通股, $14.73
$Stemline医疗(STML)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-08-09 AccNo: 0001104659-19-045072 Size: 512 KB 网页链接
$Stemline医疗(STML)$ 8-K - Current report Filed: 2019-08-09 AccNo: 0001104659-19-045073 Size: 342 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Stemline医疗(STML)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-08-08 AccNo: 0001104659-19-044678 Size: 495 KB 网页链接
$Stemline医疗(STML)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-06 AccNo: 0001104659-19-044314 Size: 8 MB 网页链接
$Stemline医疗(STML)$ 8-K - Current report Filed: 2019-08-02 AccNo: 0001104659-19-043543 Size: 203 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接